EndoGastric Solutions Company

EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.

Founded Date: 2003-05-01
Technology: P4 Medicine
Investor Type: For Profit
Funding Status: Late Stage Venture
Total Funding: $335.2M
Employee Number: 51-100
Headquarters: San Mateo, California, United States
Investors Number: 12
Last Funding Type: Series I
Estimated Revenue: $10M to $50M
Industry: Health Care, Health Diagnostics, Medical Device